ES2657907T3 - Aplicaciones terapéuticas de ectoína - Google Patents
Aplicaciones terapéuticas de ectoína Download PDFInfo
- Publication number
- ES2657907T3 ES2657907T3 ES12780649.5T ES12780649T ES2657907T3 ES 2657907 T3 ES2657907 T3 ES 2657907T3 ES 12780649 T ES12780649 T ES 12780649T ES 2657907 T3 ES2657907 T3 ES 2657907T3
- Authority
- ES
- Spain
- Prior art keywords
- ectoin
- composition
- cells
- inflammation
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011113059 | 2011-09-09 | ||
| DE102011113059A DE102011113059A1 (de) | 2011-09-09 | 2011-09-09 | Therapeutische Anwendungen von Ectoin |
| PCT/EP2012/003757 WO2013034299A1 (de) | 2011-09-09 | 2012-09-07 | Therapeutische anwendungen von ectoin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2657907T3 true ES2657907T3 (es) | 2018-03-07 |
Family
ID=47115708
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12780649.5T Active ES2657907T3 (es) | 2011-09-09 | 2012-09-07 | Aplicaciones terapéuticas de ectoína |
| ES17189829T Active ES2795879T3 (es) | 2011-09-09 | 2012-09-07 | Aplicaciones terapéuticas de ectoína |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17189829T Active ES2795879T3 (es) | 2011-09-09 | 2012-09-07 | Aplicaciones terapéuticas de ectoína |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140315869A1 (enExample) |
| EP (2) | EP2753330B1 (enExample) |
| JP (2) | JP6250542B2 (enExample) |
| CN (1) | CN103857394A (enExample) |
| BR (1) | BR112014005414A2 (enExample) |
| CA (1) | CA2848010A1 (enExample) |
| DE (1) | DE102011113059A1 (enExample) |
| ES (2) | ES2657907T3 (enExample) |
| IN (1) | IN2014CN02458A (enExample) |
| PL (2) | PL2753330T3 (enExample) |
| RU (1) | RU2648475C2 (enExample) |
| WO (1) | WO2013034299A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160106747A1 (en) * | 2008-01-30 | 2016-04-21 | Bitop Ag | Treating postoperative mechanical stress with an ectoine |
| DE102008039231A1 (de) | 2008-08-22 | 2010-02-25 | Bitop Ag | Verwendung von Glucosylglycerol |
| DE102014007423A1 (de) * | 2014-05-22 | 2015-11-26 | Bitop Ag | Zusammensetzung zur Behandlung des Auges |
| DE102014113781A1 (de) * | 2014-09-23 | 2016-03-24 | Bitop Ag | Solut und Solutgemisch sowie eine Zusammensetzung enthaltend mindestens ein Solut zur Verwendung bei der Prävention oder Behandlung von durch Schwebstaub verursachter kosmetischer oder pathologischer Effloreszenzen |
| DE102015121050A1 (de) * | 2015-12-03 | 2017-06-08 | Bitop Ag | Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben |
| DE102016104470A1 (de) | 2016-03-11 | 2017-09-14 | Bitop Ag | Zusammensetzung zur Förderung der Aktivität von Sirtuinen |
| CN111936142A (zh) * | 2018-04-05 | 2020-11-13 | 株式会社资生堂 | Asmt表达促进剂 |
| CN114425056A (zh) * | 2020-10-14 | 2022-05-03 | 宁波希诺赛生物科技有限公司 | 一种用于改善哮喘的干细胞外泌体组合物 |
| CN116570525B (zh) * | 2023-06-30 | 2025-09-23 | 华熙生物科技股份有限公司 | 一种具有舒缓功效的组合物及其制备方法和用途 |
| PL448505A1 (pl) * | 2024-05-08 | 2025-11-12 | Szkoła Główna Gospodarstwa Wiejskiego w Warszawie | Kompozycja o właściwościach barierowych i wirusobójczych wobec koronawirusów, zwłaszcza SARS-CoV-2, sposób jej otrzymywania i zastosowanie |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4244580A1 (de) | 1992-12-31 | 1994-07-07 | Galinski Erwin A | Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen |
| DE4342560A1 (de) * | 1993-12-14 | 1995-06-22 | Marbert Gmbh | Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten |
| NZ512383A (en) * | 1998-12-22 | 2003-05-30 | Univ North Carolina | Use of osmotic agents in the treatment of airway diseases and for the delivery of airway drugs |
| ATE247981T1 (de) * | 1999-06-12 | 2003-09-15 | Bitop Ag | Proteinenthaltende pharmazeutische zubereitung |
| DE10006578C2 (de) * | 2000-02-14 | 2002-10-31 | Bitop Ag | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
| DE10065986A1 (de) | 2000-12-21 | 2002-07-11 | Bitop Gmbh | Kompatible Solute als Stabilisatoren für Impfstoffe und Vakzine |
| DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
| DE10330768A1 (de) | 2003-07-07 | 2005-02-24 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung |
| DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
| DE102007040615A1 (de) * | 2007-08-27 | 2009-03-05 | Bitop Ag | Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen |
-
2011
- 2011-09-09 DE DE102011113059A patent/DE102011113059A1/de active Pending
-
2012
- 2012-09-07 EP EP12780649.5A patent/EP2753330B1/de active Active
- 2012-09-07 PL PL12780649T patent/PL2753330T3/pl unknown
- 2012-09-07 CN CN201280049557.3A patent/CN103857394A/zh active Pending
- 2012-09-07 WO PCT/EP2012/003757 patent/WO2013034299A1/de not_active Ceased
- 2012-09-07 IN IN2458CHN2014 patent/IN2014CN02458A/en unknown
- 2012-09-07 PL PL17189829T patent/PL3287131T3/pl unknown
- 2012-09-07 EP EP17189829.9A patent/EP3287131B1/de active Active
- 2012-09-07 RU RU2014113906A patent/RU2648475C2/ru not_active IP Right Cessation
- 2012-09-07 CA CA2848010A patent/CA2848010A1/en not_active Abandoned
- 2012-09-07 JP JP2014528897A patent/JP6250542B2/ja active Active
- 2012-09-07 ES ES12780649.5T patent/ES2657907T3/es active Active
- 2012-09-07 ES ES17189829T patent/ES2795879T3/es active Active
- 2012-09-07 BR BR112014005414A patent/BR112014005414A2/pt not_active Application Discontinuation
- 2012-09-07 US US14/343,017 patent/US20140315869A1/en not_active Abandoned
-
2017
- 2017-07-07 JP JP2017133770A patent/JP6396544B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2753330T3 (pl) | 2018-05-30 |
| JP6396544B2 (ja) | 2018-09-26 |
| JP6250542B2 (ja) | 2017-12-20 |
| BR112014005414A2 (pt) | 2017-04-04 |
| EP2753330A1 (de) | 2014-07-16 |
| RU2648475C2 (ru) | 2018-03-26 |
| DE102011113059A1 (de) | 2013-03-14 |
| CN103857394A (zh) | 2014-06-11 |
| EP3287131A1 (de) | 2018-02-28 |
| IN2014CN02458A (enExample) | 2015-08-07 |
| RU2014113906A (ru) | 2015-10-20 |
| ES2795879T3 (es) | 2020-11-25 |
| US20140315869A1 (en) | 2014-10-23 |
| CA2848010A1 (en) | 2013-03-14 |
| EP3287131B1 (de) | 2020-03-04 |
| WO2013034299A1 (de) | 2013-03-14 |
| PL3287131T3 (pl) | 2020-10-19 |
| JP2017197569A (ja) | 2017-11-02 |
| EP2753330B1 (de) | 2017-11-08 |
| JP2014526448A (ja) | 2014-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2657907T3 (es) | Aplicaciones terapéuticas de ectoína | |
| JP6795574B2 (ja) | Ｒｐｌ５５４を含む液体吸入製剤 | |
| AU2021251689B2 (en) | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs | |
| AU2003278744B2 (en) | Therapeutic treatment methods | |
| ES2946179T3 (es) | Efectos antineoplásicos de inhibidores de JAK2 en combinación con derivados de talidomida y glucocorticoides | |
| ES2741439T3 (es) | Compuestos aromáticos sustituidos | |
| ES2710288T3 (es) | Medicamentos y usos | |
| CN106163528A (zh) | 用于治疗肝脑病的甾族化合物 | |
| EP2552199A1 (en) | Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | |
| WO2009071990A2 (en) | No-donating cordicosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties | |
| RU2242972C2 (ru) | Ингаляционный состав для лечения бронхиальной астмы | |
| EP2808025B1 (en) | Pharmaceutical composition and quasi-drug cosmetic using same | |
| RU2013148786A (ru) | Улучшенный состав суспензии кортикостероида для ингаляционного введения | |
| JP2024528010A (ja) | 気管支肺異形成症（ｂｐｄ）及びｂｐｄ関連肺高血圧症の治療のための組成物及び方法 | |
| JPWO2012147705A1 (ja) | トレハロースを含有する炎症性呼吸器疾患の治療剤 | |
| US20230041980A1 (en) | Method of protecting a respiratory tract or a lung from damage, method of protecting a lung from pressure damage induced by a ventilator, method of suppressing spread of infection with viruses or bacteria that cause pneumonia in pulmonary bronchial epithelial cells or alveolar epithelial cells, and nasal spray | |
| EP4501326A1 (en) | Therapeutic agent for respiratory disease | |
| EP4010351B1 (en) | Montelukast esters and pharmaceutical compositions containing the same | |
| ES2365533T3 (es) | Combinación de andolast / glucocorticoides. | |
| EP4486317A1 (en) | Chromanol compounds for treatment or prophylaxis of ageing-associated disorders | |
| TWI750481B (zh) | 用於中風治療之巴豆酯組成物及使用方法 | |
| BR112017005050B1 (pt) | Composições farmacêuticas líquidas, nebulizador e usos da composição farmacêutica líquida | |
| HK1204556B (en) | Pharmaceutical composition and quasi-drug cosmetic using same |